Analyst Reco. Cellectis S.A. Nasdaq

Equities

CLLS

US15117K1034

Market Closed - Nasdaq Other stock markets 21:00:00 21/06/2024 BST			5-day change	1st Jan Change
1.89 ^USD	-3.77%		-16.00%	-38.64%

06-21	European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher	MT
06-20	European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Trims Cellectis Price Target to $10 From $11, Maintains Outperform Rating	06-12	MT
European Earnings, Rate-hike Predictions Push French Stocks to Red	25/04/23	MT
Citigroup Adjusts Cellectis Price Target to $16 From $24, Maintains Buy Rating	05/04/23	MT
Oppenheimer Adjusts Cellectis Price Target to $13 From $16, Maintains Outperform Rating	13/03/23	MT
Goldman Sachs Adjusts Cellectis' Price Target to $2 from $3, Keeps Sell Rating	24/05/22	MT
Baird Upgrades Cellectis to Outperform From Neutral	18/05/22	MT
Barclays Lowers Cellectis S.A's Price Target to $7 From $9, Overweight Rating Maintained	13/05/22	MT
Wells Fargo Downgrades Cellectis to Equalweight From Overweight; Price Target is $16	06/01/22	MT
JMP Securities Starts Cellectis at Market Outperform With $20 Price Target	30/11/21	MT
CELLECTIS S A : Baird Downgrades Cellectis to Neutral from Outperform, Adjusts Price Target to $10 from $39	08/10/21	MT
CELLECTIS S A : Guggenheim Downgrades Cellectis to Neutral from Buy	28/04/21	MT
CELLECTIS S A : Baird Upgrades Cellectis to Outperform From Neutral, Adjusts Price Target to $39 From $23	16/03/21	MT
Cellectis S.A. and Pfizer Inc. Completes Remission Rate Across Two Phase I Adult and Pediatric Acute Lymphoblastic Leukemia Trials	12/12/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer